➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Colorcon
Dow
AstraZeneca
Moodys

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2013)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-08-22 1 Exhibit A US 6,335,031 B1 Asmussen et al. … US 6,335,031 B1 1 … US 6,335,031 B1 3 … US 6,335,031 B1 5 … US 6,335,031 B1 7 External link to document
2013-11-18 16 United States Letters Patent No. 6,335,031 (“the ‘031 patent”). The ‘031 patent was duly and legally issued… 9606290v.l BACKGROUND 9. U.S. Patent l\lo. 6,335,031 (“’031 patent”) entitled “TTS containing an antioxidant…Act, 28 U.S.C. § 2201 el seq., that U.S. Patent No. 6,335,031 is invalid and not infringed by Par. JURISDICTION…Declaratory .]udgment regarding invalidity of U.S. Patent No. 6,335,031) 13. Par realleges paragraphs 1-12 of the…Judgment regarding non-infringement of U.S. Patent No. 6,335,031) 16. Par realleges paragraphs 1-12 of the External link to document
2013-08-22 3 Date of Expiration of Patent: 6,335,031 (January 8, 2019 ) … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 07/12/2013. Date of Expiration of Patent: 01/08/2019.Thirty Month Stay Deadline: 1/12/2016… SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW… 17 September 2014 1:13-cv-01467 830 Patent None District Court, D. Delaware External link to document
2013-08-22 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,335,031;. (dmp, ) (Entered:…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 6,335,031 … G ✔ Patents. ( G the patent action involves 35 U.S.C. § 292.): …Therapie-Systeme AG PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Moodys
Merck
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.